warns Big Pharma will pull out of Britain unless it starts paying for new
companies will leave the UK unless its government and National Health Service
start to pay for “breakthrough” drugs, particularly cancer treatments,
a senior executive at AstraZeneca has warned.
who still doubts that the pharma industry exerts political and economic
pressure on our governments, this story provides the proof. Increasingly,
unscrupulous drug makers are demanding that national health services spend
more money on the toxic synthetic chemicals they manufacture as the supposed
answers to diseases.
however, the global healthcare crisis isn’t due to a lack of funding,
but to ineffective therapies. Solving this crisis does not depend simply
on throwing increased amounts of money at the problem. Unless money is properly
utilized and deliberately targeted towards addressing the primary cause
of chronic diseases, namely, micronutrient deficiencies, our healthcare
systems will inevitably remain trapped in an endless cycle of ineffectively
treating symptoms at an ever-increasing cost.
healthcare reform involves recognizing the primary cause of chronic diseases
and taking action to protect populations through the preventive use of science-based
natural health approaches. Let’s hope that somewhere, sooner or later,
a government is elected that understands this.